Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
18%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
8%
ALSO IN OZEM
OZEM
20
HOLDINGS
50%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IXJ |
Weight in OZEM |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 7.8% | 15.6% | 7.8% | |
ROCHE HOLDING LTD | 3.2% | 5.3% | 3.2% | |
AMGEN INC | 2.2% | 3.3% | 2.2% | |
PFIZER INC | 2.1% | 4.0% | 2.1% | |
GILEAD SCIENCES INC | 2.0% | 1.6% | 1.6% |
IXJ Overweight Relative to OZEM
JOHNSON & JOHNSON | 6.0% | |
ABBVIE INC | 5.2% | |
UNITEDHEALTH GROUP INC | 3.9% | |
ASTRAZENECA PLC | 3.5% | |
NOVARTIS AG | 3.4% | |
ABBOTT LABORATORIES | 3.2% | |
MERCK & CO. INC. | 3.1% | |
THERMO FISHER SCIENTIFIC INC | 2.6% | |
NOVO NORDISK A/S-B | 2.5% | |
INTUITIVE SURGICAL INC | 2.4% |
IXJ Underweight Relative to OZEM
NOVO-NORDISK A/S-SPONS ADR | -19.8% | |
ELI LILLY & CO | -7.8% | |
ZEALAND PHARMA A/S | -6.3% | |
INNOVENT BIOLOGICS, INC. | -4.4% | |
CHUGAI PHARMACEUTICAL CO LTD | -4.1% | |
ASTRAZENECA PLC-SPONS ADR | -3.4% | |
HANMI PHARM CO LTD | -3.0% | |
VIKING THERAPEUTICS, INC. | -2.9% | |
TERNS PHARMACEUTICALS, INC. | -2.8% | |
SCHOLAR ROCK HOLDING CORP. | -2.5% |